HCC patients with high- and low-EXO1 expression levels showed significant differences in the clinical T stages, pathological stages, tumor status, histological stages, alpha-fetoprotein (AFP) levels, overall survival (OS), and disease-specific survival (DSS). This evidence concerns the gene AFP and neoplasm.